• With mountain of opioid lawsuits, Endo files for bankruptcy

    Endo International, an Ireland and Malvern, Pa.-based pharmaceutical company, filed for bankruptcy Aug. 16 as it shoulders about 31,000 lawsuits accusing the company of fueling the opioid crisis, according to The Wall Street Journal. 
  • Omicron-tweaked vaccines could be for everyone 12 and up, White House says

    The updated COVID-19 boosters aimed at targeting omicron subvariants BA.4 and BA.5 could soon be authorized for people 12 and older, White House COVID-19 response coordinator Ashish Jha, MD, told NBC News Aug. 17.
  • Pharma giants slam Medicare drug price negotiation

    The Inflation Reduction Act of 2022 opens the door for Medicare to negotiate prices for certain drugs — a change that drug manufacturers strongly oppose. 
  • Fed up with reduced hours, staffing shortages, customers shift to local pharmacies

    As Walgreens is offering bonuses up to $75,000 to recruit pharmacists and workforce shortages are hindering pharmacy services, such as prescribing COVID-19 antiviral drugs, some local pharmacies may soon see more customers. 
  • Digital pharmacy Medly lays off 16% of staff

    Medly Pharmacy has let go of 16 percent of its workforce, the digital pharmacy's chief executive wrote in a recent LinkedIn post.
  • Sanofi scraps breast cancer drug candidate

    Global drugmaker Sanofi is dropping its treatment intended for breast cancer after a phase 3 trial with other drugs failed to meet progression-free survival goals. 
  • 10 systems seeking pharmacy leaders

    The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
  • Moderna taps new CFO

    Vaccine-maker Moderna appointed James Mock to become the Cambridge, Mass-based company's CFO starting Sept. 6. 
  • J&J business argues bankruptcy is only option in talc lawsuits

    A subsidiary of pharmaceutical company Johnson & Johnson, LTL Management, said in court documents that bankruptcy is the only option to settle the thousands of lawsuits lodged against J&J's talc-based baby powder, The Wall Street Journal reported Aug. 16. 
  • FDA hits Emergent BioSolutions facility with 'significant violations'

    In a volley between the FDA and Emergent BioSolutions over the biotech's Baltimore facility, the agency said Emergent was "inadequate" in its efforts to fix drug manufacturing errors. 
  • Novavax eyes COVID-19 booster authorization from FDA

    Novavax, a pharmaceutical company that recently gained the FDA's emergency use authorization for its COVID-19 vaccine, is now pushing for its booster candidate to be authorized for adults.
  • Merck pays $150M in partnership with biotech company

    Pharmaceutical company Merck is partnering with biotechnology company Orna Therapeutics to develop treatments in oncology and infectious diseases; Merck will pay $150 million upfront to Orna.
  • Century-old tuberculosis vaccine may protect against COVID-19, study finds

    A tuberculosis vaccine that's 100 years old and costs less than a dollar per dose could have a shot at preventing COVID-19 infections, according to researchers from Boston's Massachusetts General Hospital.
  • Pfizer's antiviral drug could result in 'Paxlovid mouth'

    Paxlovid, Pfizer's popular antiviral drug treatment, is leaving a sour taste in people's mouths, The Wall Street Journal reported Aug. 16.
  • How the dismissal of Roe affects pregnancy products

    After Roe v. Wade was overturned in June, access to some drugs and pharmacy products related to pregnancy, such as condoms, has been strained, and some pharmacies are scrambling to provide healthcare without breaking laws.
  • Digital pharmacy Truepill cuts 14% of staff in another round of layoffs

    Truepill has reduced its global workforce by 14 percent in another round of job cuts for the digital pharmacy, a spokesperson told Becker's.
  • Rite Aid partners with WellSpan Health

    Rite Aid will team up with WellSpan Health, an eight-hospital system with locations scattered across Pennsylvania and Maryland, to weave the two organizations' priorities together and improve health outcomes of patients.
  • Pfizer CEO tests positive for COVID-19

    Pfizer Chairman and CEO Albert Bourla, PhD, has tested positive for COVID-19, the executive said in an Aug. 15 statement on the company's website. 
  • Boston biopharma company's acquisition completed

    Cambridge, Mass.-based healthcare investment fund Gurnet Point Capital and Menlo Park Calif.-based healthcare investment firm Patient Square Capital completed their acquisition of biopharmaceutical company Radius Health, the company said Aug. 15.
  • Walgreens scoops services from 80+ grocery chain pharmacies

    Save Mart, a grocery store chain concentrated in California and Nevada, plans to shutter its 89 pharmacies and move its services to Walgreens Aug. 16, according to the Reno Gazette Journal and the Union Democrat. 

Featured Whitepapers

Featured Webinars